Skip to content

Evaluation of effectiveness of an Ayurvedic toothpaste in periodontitis patients

Evaluation of effectiveness of an Ayurvedic toothpaste in periodontitis patients-A Randomized Controlled Clinical Trial - NA

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/11/097356
Enrollment
60
Registered
2025-11-13
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K053- Chronic periodontitis

Interventions

Intervention1: Edinora prime tooth paste: Instructions-Advised to use the tooth paste and brush daily for two minutes using modified bass technique. Ingredients-Glycyrrhiza glabra, Embilica officina

Sponsors

Aparna M Nair
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Generalized stage III periodontitis patients according to criteria given by American Academy of Periodontology 2017 classification. 2. Periodontal disease as indicated by at least 1 site in each quadrant with Pocket Depth (PD) in the range of 6 -8 mm with Bleeding on Probing (BOP) 3. Those who are willing to participate in the study

Exclusion criteria

Exclusion criteria: 1. Pregnancy or lactation 2. Subjects currently undergoing orthodontic therapy 3. Inflammatory conditions associated with skin and oral mucosa 4. The use of prescription antibiotics, mouth rinse, corticosteroids, or anti- inflammatory drugs within the past three months 5. Recent periodontal therapy within the last six months.

Design outcomes

Primary

MeasureTime frame
Percentage reduction in number of periodontal pockets with PPD ≥ 4mm with bleeding on probing in group treated with Edinora dentifrice compared to control groupTimepoint: At 3 months & 9 months

Secondary

MeasureTime frame
1. Change in oral microbiome profile in group treated with Edinora dentifrice compared to control group 2. Reduction in the salivary IL-1β levels measured using ELISA in group treated with Edinora dentifrice compared to control group 3. Change in salivary lipoxin A4 measured using ELISA in group treated with Edinora dentifrice compared to control group Timepoint: At 3 months & 9 months

Countries

India

Contacts

Public ContactDr Aparna M Nair
aparnamnair3@gmail.com8547743056

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026